Plain-English translation of NCT06847438 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Heart Failure research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a simple checklist — called the EPIC-HF checklist — can help patients and their doctors make better choices about heart failure medications. The checklist shows patients what medications doctors recommend and at what doses, so they can compare it to what they're currently taking. Researchers want to see if this tool helps more patients get prescribed the right medications and improves their heart health outcomes.
Many patients with heart failure don't receive newer, proven medications that could help them, even though medical guidelines strongly recommend these treatments. This study aims to find out whether giving patients and doctors a simple comparison tool before appointments can increase the use of these important medications and improve care.
If you are assigned to the checklist group, you will receive the EPIC-HF checklist through your clinic's patient portal before your appointments, allowing you to review recommended medications and doses ahead of time. Some clinics will also give the same checklist tool to your doctors to help with their prescribing decisions. You will continue your regular heart failure clinic visits over a 12-month period (two 6-month phases), and researchers will track whether the checklist helps improve your medication prescriptions and health outcomes. If you are in the standard care group, you will receive normal heart failure care without the checklist.
AI-generated summary from trial data · Jul 16, 2026 · Not medical advice
United States